Insider · CIK 0001134365

MIGAUSKY GEORGE V

Reports to the SEC for 8 companies · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001134365

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-29	RGNXREGENXBIO Inc.A Award	Director	AAward	+9,807 sh	—	—	28,861
2026-05-29	RGNXREGENXBIO Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+46.6K sh	—	—	46,600
2025-05-30	RGNXREGENXBIO Inc.A Award	Director	AAward	+7,768 sh	—	—	19,054
2025-05-30	RGNXREGENXBIO Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+39.8K sh	—	—	39,815
2025-04-01	IMVTImmunovant, Inc.A Award	Director	AAward	+16.2K sh	—	—	137,251
2025-04-01	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,600 sh	—	—	7,600
2024-05-31	RGNXREGENXBIO Inc.A Award	Director	AAward	+4,790 sh	—	—	11,286
2024-05-31	RGNXREGENXBIO Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+24.5K sh	—	—	24,454
2024-04-02	IMVTImmunovant, Inc.A Award	Director	AAward	+11.3K sh	—	—	121,063
2024-04-02	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Director	AAward	+4,690 sh	—	—	4,690
2023-12-01	IMVTImmunovant, Inc.S Sale	Director	SSale	−4,200 sh	$38.79	−$163K	118,308
2023-12-01	IMVTImmunovant, Inc.S Sale	Director	SSale	−3,478 sh	$39.81	−$138K	114,830
2023-12-01	IMVTImmunovant, Inc.S Sale	Director	SSale	−5,022 sh	$40.46	−$203K	109,808
2023-06-02	RGNXREGENXBIO Inc.A Award	Director	AAward	+3,486 sh	—	—	6,496
2023-06-02	RGNXREGENXBIO Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+17.9K sh	—	—	17,892
2023-04-12	IMVTImmunovant, Inc.A Award	Director	AAward	+12.5K sh	—	—	122,508
2023-04-12	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16.3K sh	—	—	16,260
2022-08-17	IMVTImmunovant, Inc.A Award	Director	AAward	+21.1K sh	—	—	109,985
2022-08-17	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Director	AAward	+31.7K sh	—	—	31,668
2022-06-03	RGNXREGENXBIO Inc.A Award	Director	AAward	+3,010 sh	—	—	3,010
2022-06-03	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15.3K sh	—	—	15,324
2022-01-10	IMVTImmunovant, Inc.A Award	Director	AAward	+21.7K sh	—	—	88,926
2022-01-10	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Director	AAward	+71.5K sh	—	—	131,792
2021-09-03	RGNXREGENXBIO Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2021-08-20	IMVTImmunovant, Inc.P Purchase	Director	PPurchase	+7,000 sh	$7.65	+$53.6K	67,200
2021-03-19	IMVTImmunovant, Inc.A Award	Director	AAward	+15.5K sh	—	—	60,200
2021-03-19	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Director	AAward	+23.3K sh	—	—	23,300
2020-06-17	ABEOABEONA THERAPEUTICS INC.A Award	Director	AAward	+38K sh	—	—	37,954
2020-06-17	ABEOABEONA THERAPEUTICS INC. · Stock Option (right to buy)A Award	Director	AAward	+45.6K sh	—	—	45,566
2020-05-15	IMVTImmunovant, Inc.A Award	Director	AAward	+24.7K sh	—	—	24,700
2020-05-15	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Director	AAward	+37K sh	—	—	37,000
2017-11-07	Dimension Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−55.8K sh	—	—	0
2017-11-07	Dimension Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−32.1K sh	—	—	0
2017-11-07	Dimension Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17K sh	—	—	0
2017-05-25	Dimension Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	17,000
2016-05-19	Dimension Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+32.1K sh	—	—	32,069
2016-01-22	DYAX CORPD Disposition to Issuer	EVP & Chief Financial Officer	DDisposition to Issuer	−752K sh	—	—	0
2016-01-22	DYAX CORPD Disposition to Issuer	EVP & Chief Financial Officer	DDisposition to Issuer	−15K sh	—	—	0
2016-01-22	DYAX CORPStock Option (right to buy)D Disposition to Issuer	EVP & Chief Financial Officer	DDisposition to Issuer	−37.9K sh	—	—	0
2016-01-22	DYAX CORPStock Option (right to buy)D Disposition to Issuer	EVP & Chief Financial Officer	DDisposition to Issuer	−3,958 sh	—	—	0
2016-01-22	DYAX CORPStock Option (right to buy)D Disposition to Issuer	EVP & Chief Financial Officer	DDisposition to Issuer	−78K sh	—	—	0
2016-01-22	DYAX CORPStock Option (right to buy)D Disposition to Issuer	EVP & Chief Financial Officer	DDisposition to Issuer	−238K sh	—	—	0
2016-01-14	DYAX CORPM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+42.7K sh	$2.39	+$102K	405,698
2016-01-14	DYAX CORPM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+87.7K sh	$3.22	+$282K	493,427
2016-01-14	DYAX CORPM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+50K sh	$3.00	+$150K	543,434
2016-01-14	DYAX CORPM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+91K sh	$1.48	+$135K	634,476
2016-01-14	DYAX CORPM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+40K sh	$2.06	+$82.4K	674,475
2016-01-14	DYAX CORPM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+15K sh	$10.20	+$153K	689,475
2016-01-14	DYAX CORPM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+62.5K sh	$15.23	+$952K	751,975
2016-01-14	DYAX CORPStock Option (right to buy)M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−42.7K sh	—	—	0

Recent filings

Accepted (ET)
Jun 24
MIGAUSKY GEORGE V0001134365-26-000001
SEC(opens sec.gov)
Jun 34
MIGAUSKY GEORGE V0001562180-25-004350
SEC(opens sec.gov)
Apr 34
MIGAUSKY GEORGE V0001764013-25-000041
SEC(opens sec.gov)
Jun 44
MIGAUSKY GEORGE V0001562180-24-004655
SEC(opens sec.gov)
Apr 44
MIGAUSKY GEORGE V0001764013-24-000063
SEC(opens sec.gov)
Dec 54
MIGAUSKY GEORGE V0001764013-23-000153
SEC(opens sec.gov)
Jun 64
MIGAUSKY GEORGE V0001562180-23-004892
SEC(opens sec.gov)
Apr 144
MIGAUSKY GEORGE V0001764013-23-000044
SEC(opens sec.gov)
Aug 194
MIGAUSKY GEORGE V0001764013-22-000093
SEC(opens sec.gov)
Jun 74
MIGAUSKY GEORGE V0001562180-22-004879
SEC(opens sec.gov)

Companies

Address

C/O REGENXBIO INC. 9804 MEDICAL CENTER DRIVE

ROCKVILLE, MD, 20850